CO2022000405A2 - Polimorfos de un inhibidor de cinasas macrocíclicas - Google Patents
Polimorfos de un inhibidor de cinasas macrocíclicasInfo
- Publication number
- CO2022000405A2 CO2022000405A2 CONC2022/0000405A CO2022000405A CO2022000405A2 CO 2022000405 A2 CO2022000405 A2 CO 2022000405A2 CO 2022000405 A CO2022000405 A CO 2022000405A CO 2022000405 A2 CO2022000405 A2 CO 2022000405A2
- Authority
- CO
- Colombia
- Prior art keywords
- polymorphs
- kinase inhibitor
- macrocyclic kinase
- mammals
- cancer
- Prior art date
Links
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962863493P | 2019-06-19 | 2019-06-19 | |
| US202062959940P | 2020-01-11 | 2020-01-11 | |
| US202063036102P | 2020-06-08 | 2020-06-08 | |
| PCT/US2020/037892 WO2020257169A1 (en) | 2019-06-19 | 2020-06-16 | Polymorphs of a macrocyclic kinase inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2022000405A2 true CO2022000405A2 (es) | 2022-04-29 |
Family
ID=74040102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2022/0000405A CO2022000405A2 (es) | 2019-06-19 | 2022-01-19 | Polimorfos de un inhibidor de cinasas macrocíclicas |
Country Status (15)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113336774B (zh) * | 2021-06-25 | 2023-05-23 | 江南大学 | 作为trk抑制剂的取代的手性二芳基大环化合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015112806A2 (en) * | 2014-01-24 | 2015-07-30 | Tp Therapeutics, Inc. | Diaryl macrocycles as modulators of protein kinases |
| RU2732405C2 (ru) * | 2015-07-02 | 2020-09-16 | Тёрнинг Поинт Терапьютикс, Инк. | Хиральные диарильные макроциклы в качестве модуляторов протеинкиназ |
| BR112018000297A2 (pt) * | 2015-07-06 | 2018-09-04 | Tp Therapeutics Inc | polimorfo de macrociclo de diarila |
| WO2017015367A1 (en) * | 2015-07-21 | 2017-01-26 | Tp Therapeutics, Inc. | Chiral diaryl macrocycles and uses thereof |
| CA3069554A1 (en) * | 2017-07-14 | 2019-01-17 | Glaxosmithkline Intellectual Property Development Limited | Inhibitors of leucine rich repeat kinase 2 |
| RS63787B1 (sr) * | 2017-12-19 | 2022-12-30 | Turning Point Therapeutics Inc | Makrociklična jedinjenja za lečenje bolesti |
-
2020
- 2020-06-16 WO PCT/US2020/037892 patent/WO2020257169A1/en not_active Ceased
- 2020-06-16 MX MX2021015756A patent/MX2021015756A/es unknown
- 2020-06-16 US US17/618,060 patent/US20220411439A1/en not_active Abandoned
- 2020-06-16 JP JP2021575515A patent/JP2022537385A/ja not_active Withdrawn
- 2020-06-16 AU AU2020294627A patent/AU2020294627A1/en not_active Abandoned
- 2020-06-16 PH PH1/2021/553174A patent/PH12021553174A1/en unknown
- 2020-06-16 KR KR1020227001994A patent/KR20220046549A/ko not_active Ceased
- 2020-06-16 EP EP20826665.0A patent/EP3986413A4/en not_active Withdrawn
- 2020-06-16 CA CA3143043A patent/CA3143043A1/en active Pending
- 2020-06-16 BR BR112021025786A patent/BR112021025786A2/pt not_active Application Discontinuation
- 2020-06-16 PE PE2021002184A patent/PE20220135A1/es unknown
- 2020-06-16 CN CN202080044953.1A patent/CN114025765A/zh active Pending
- 2020-06-19 TW TW109120778A patent/TW202115090A/zh unknown
-
2021
- 2021-12-14 IL IL288982A patent/IL288982A/en unknown
-
2022
- 2022-01-19 CO CONC2022/0000405A patent/CO2022000405A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH12021553174A1 (en) | 2022-08-01 |
| WO2020257169A1 (en) | 2020-12-24 |
| MX2021015756A (es) | 2022-01-27 |
| AU2020294627A1 (en) | 2022-02-17 |
| IL288982A (en) | 2022-02-01 |
| PE20220135A1 (es) | 2022-01-27 |
| JP2022537385A (ja) | 2022-08-25 |
| BR112021025786A2 (pt) | 2022-02-01 |
| KR20220046549A (ko) | 2022-04-14 |
| CA3143043A1 (en) | 2020-12-24 |
| TW202115090A (zh) | 2021-04-16 |
| EP3986413A4 (en) | 2023-06-14 |
| CN114025765A (zh) | 2022-02-08 |
| US20220411439A1 (en) | 2022-12-29 |
| EP3986413A1 (en) | 2022-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021008145A (es) | Polimorfo de macrociclo de diarilo. | |
| CO2020015226A2 (es) | Formas sólidas de un inhibidor de fgfr y procesos para prepararlas | |
| MX2018000718A (es) | Macrociclos de diarilo quirales y usos de los mismos. | |
| MX2021013661A (es) | Inhibidores de la autofagia de fenilaminopirimidina amida y metodos de uso de estos. | |
| CO2021016765A2 (es) | Inhibidores de la autofagia de heteroarilaminopirimidina amida y métodos de uso de estos | |
| CL2021002995A1 (es) | (divisional de solicitud 2922-2020) derivados de tetrahidro-imidazo[4,5-c]piridina como inmunomoduladores de pd-l1. | |
| IL276501A (en) | CGAS inhibitors containing 2,3,4,5-tetrahydro-1H-pyrado[B-4,3]indoles for the treatment of autoinflammatory diseases | |
| MX376174B (es) | 1h-pirrolo[2,3-c]piridin-7(6h)-onas y pirazolo[3,4-c]piridin-7(6h)-onas como inhibidores de proteinas de bromodominio y extra terminal (bet). | |
| MX2023007162A (es) | Macrociclos y sus usos. | |
| MX2019003649A (es) | Inhibidores selectivos de jak1 novedosos y usos de los mismos. | |
| ECSP099400A (es) | Imidazotriazinas e imidazopirimidinas como inhibidores de cinasa | |
| MX2023000782A (es) | 7-bencil-4-(2-metilbencilo)-2,4,6,7,8,9-hexahidroimidazo [1,2-a]pirido[3,4-e]pirimidin-5(1h)-ona, analogos y sales del mismo y su uso en terapia. | |
| UY37559A (es) | Pirazolo[3,4-b]piridina y pirrolo[2,3-b]piridina como inhibidores de la tirosina quinasa de bruton | |
| CL2021001656A1 (es) | Compuestos de imidazopiridina e imidazopiridina y sus usos. | |
| CO2019005538A2 (es) | Pirazolo[3,4-b]piridinas e imidazo[1,5-b]piridazinas como inhibidores de pde1 | |
| CO6420343A2 (es) | [1, 2, 4] triazolo [1, 5 -a] piridinas como inhibidores de cinasa | |
| DOP2025000213A (es) | [1,3]tiazolo[4,5-d]-pirimidin-7-onas como inhibidores de la nox4 | |
| CO2017003538A2 (es) | Inhibidores de histona desmetilasa derivados de 2-oxipirido[ 3,4-d]pirimidin-4-ol | |
| NI200700318A (es) | Benzocicloheptapiridinas como inhibidores de la tirosina quinasa de receptor met | |
| CO2026005573A2 (es) | Compuestos heterobifuncionales y métodos de tratamiento de enfermedades | |
| PE20191789A1 (es) | Compuestos heterociclicos biciclicos sustituidos como inhibidores de la nadph oxidasa | |
| PE20220135A1 (es) | Polimorfos de un inhibidor de cinasas macrociclicas | |
| MX2022010945A (es) | Usos terapeuticos de compuestos macrociclicos. | |
| MY203494A (en) | 6h-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivative | |
| CO2026004945A2 (es) | Compuestos 5-oxo-4,5-dihidroimidazo[1,5-a]quinazolina como inhibidores de pi3k[alfa] |